CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, today announced the publication of its ...
Cardiovascular diseases remain the leading cause of death worldwide, accounting for nearly 20 million deaths each year. Rapid diagnosis and risk assessment of cardiac injury are therefore essential ...
In a significant advancement for point-of-care medical diagnostics, a team of researchers from UCLA has introduced a deep learning-enhanced, paper-based vertical flow assay (VFA) capable of detecting ...
Cardio Diagnostics today announced that Atlas Healthcare Physicians (AHP) will cover Cardio Diagnostics’ tests, Epi+Gen CHD™ and PrecisionCHD™.
Cardio Diagnostics Holdings (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, announced that Atlas Healthcare Physicians, an independent physician association serving managed ...
A new study finds that cardiovascular diagnostic testing has yet to return to prepandemic levels in some regions of the world, and that excess pandemic-related stress among physicians and testing ...
Morning Overview on MSN
An AI blood test can flag six heart threats up to 15 years early
Researchers at the University of Hong Kong’s medical school have built an AI system that reads a single blood sample and ...
TORONTO, June 15, 2026 /CNW/ - Heart & Stroke is pleased with the Ontario government's decision to expand publicly funded access to key cardiovascular diagnostic tests, including natriuretic peptide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results